Stem Cell Therapy Market Worth $330 Million in 2020 - New Report by MarketsandMarkets
(PRWEB) May 26, 2014 -- The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW).
Browse 57 market data tables 32 figures spread through 196 Slides and in-depth TOC on “Stem Cell Therapy Market”.
http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
Early buyers will receive 10% customization on report.
The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. In addition, based on the therapeutic applications, the global stem cell therapy market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others.
Inquire before buying at http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=48.
This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.
Download PDF brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=48.
A number of factors such as increasing funding from various government and private organizations, growing industry focus on stem cell research, and rising global awareness about stem cell therapies through various organizations are driving the growth of the global market. In addition, increasing funding for new stem cell lines, development of advanced genomic methods for stem cell analysis, and rising approvals of clinical trials for stem cell therapy are other factors that are propelling the growth of the market.
However, factors such as lack of required infrastructure, ethical issues related to embryonic stem cell, and difficulties related with the preservation of stem cell are restraining the growth of the market.
The global stem cell market in 2015 is expected to be dominated by North America, followed by Asia-Pacific and Europe. However, Asia-Pacific market is expected to surpass North America by 2020, owing to the high number of ongoing research activities. Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centred in Japan, South Korea, China, and India. A number of factors such as the increasing regulatory support through favourable government policies, strong product pipelines, increasing licensing activities, and growing focus of both international and domestic players on the Asia-Pacific stem cell therapy market pose as the key drivers to the growth of market..
The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe.
Browse Related Reports:
Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018 http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html
Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017)
http://www.marketsandmarkets.com/Market-Reports/transfection-technologies-market-895.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/pharmaceuticals.
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets.
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article